Overexpression of TG-interacting factor is associated with worse prognosis in upper urinary tract urothelial carcinoma

American Journal of Pathology

Volumn 181, Issue 3, 2012, Pages 1044-1055

  Yeh, Bi Wen ^a   Wu, Wen Jeng ^b,c   Li, Wei Ming ^b   Li, Ching Chia ^b   Huang, Chun Nung ^b   Kang, Wan Yi ^d   Liu, Zi Miao ^a   Huang, Huei Sheng ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d KUO GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MATRIX METALLOPROTEINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P21; TRANSFORMING GROWTH FACTOR;

AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CELL MIGRATION; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETINOBLASTOMA; TRANSITIONAL CELL CARCINOMA; UPREGULATION; URINARY TRACT CARCINOMA;

AGED; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE-FREE SURVIVAL; FEMALE; G1 PHASE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PSEUDOPODIA; REPRESSOR PROTEINS; S PHASE; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84865014506     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.05.024     Document Type: Article

References (58)

1. A. Jemal, R. Siegel, J. Xu, E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. M. Ploeg, K.K. Aben, L.A. Kiemeney The present and future burden of urinary bladder cancer in the world World J Urol 27 2009 289 293
3. B.L. Jacobs, C.T. Lee, J.E. Montie Bladder cancer in 2010: how far have we come CA Cancer J Clin 60 2010 244 272
4. M. Roupret, R. Zigeuner, J. Palou, A. Boehle, E. Kaasinen, R. Sylvester, M. Babjuk, W. Oosterlinck European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update Eur Urol 59 2011 584 594
5. G.A. Brown, J.E. Busby, C.G. Wood, L.L. Pisters, C.P. Dinney, D.A. Swanson, H.B. Grossman, C.A. Pettaway, M.F. Munsell, A.M. Kamat, S.F. Matin Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm BJU Int 98 2006 1176 1180
6. J.J. Munoz, L.M. Ellison Upper tract urothelial neoplasms: incidence and survival during the last 2 decades J Urol 164 2000 1523 1525
7. J.D. Raman, J. Messer, J.A. Sielatycki, C.S. Hollenbeak Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 19732005 BJU Int 107 2011 1059 1064
8. V. Margulis, S.F. Shariat, S.F. Matin, A.M. Kamat, R. Zigeuner, E. Kikuchi, Y. Lotan, A. Weizer, J.D. Raman, C.G. Wood Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration Cancer 115 2009 1224 1233
9. T.F. Chromecki, K. Bensalah, M. Remzi, G. Verhoest, E.K. Cha, D.S. Scherr, G. Novara, P.I. Karakiewicz, S.F. Shariat Prognostic factors for upper urinary tract urothelial carcinoma: nature reviews Urology 8 2011 440 447
10. G. Lughezzani, M. Burger, V. Margulis, S.F. Matin, G. Novara, M. Roupret, S.F. Shariat, C.G. Wood, R. Zigeuner Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature Eur Urol 62 2012 100 114
11. M.H. Yang, K.K. Chen, C.C. Yen, W.S. Wang, Y.H. Chang, W.J. Huang, F.S. Fan, T.J. Chiou, J.H. Liu, P.M. Chen Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan Urology 59 2002 681 687
12. C.C. Li, T.H. Chang, W.J. Wu, H.L. Ke, S.P. Huang, P.C. Tsai, S.J. Chang, J.T. Shen, Y.H. Chou, C.H. Huang Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients Eur Urol 54 2008 1127 1134
13. W.M. Li, C.C. Li, H.L. Ke, W.J. Wu, C.N. Huang, C.H. Huang The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy J Urol 182 2009 451 458
14. M.N. Lai, S.M. Wang, P.C. Chen, Y.Y. Chen, J.D. Wang Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk J Natl Cancer Inst 102 2010 179 186
15. C.Y. Yang, H.F. Chiu, C.C. Chang, S.C. Ho, T.N. Wu Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan Environ Res 98 2005 127 132
16. H.Y. Yang, J.D. Wang, T.C. Lo, P.C. Chen Increased risks of upper tract urothelial carcinoma in male and female Chinese herbalists J Formos Med Assoc 110 2011 161 168
17. H.S. Huang, Z.M. Liu, D.Y. Hong Blockage of JNK pathway enhances arsenic trioxide-induced apoptosis in human keratinocytes Toxicol Appl Pharmacol 244 2010 234 241
18. WAF1/CIP1 expression J Biomed Sci 15 2008 333 342
19. L. Bartholin, S.E. Powers, T.A. Melhuish, S. Lasse, M. Weinstein, D. Wotton TGIF inhibits retinoid signaling Mol Cell Biol 26 2006 990 1001
20. D. Wotton, R.S. Lo, L.A. Swaby, J. Massague Multiple modes of repression by the Smad transcriptional corepressor TGIF J Biol Chem 274 1999 37105 37110
21. E. Bertolino, B. Reimund, D. Wildt-Perinic, R.G. Clerc A novel homeobox protein which recognizes a TGT core and functionally interferes with a retinoid-responsive motif J Biol Chem 270 1995 31178 31188
22. K.W. Gripp, D. Wotton, M.C. Edwards, E. Roessler, L. Ades, P. Meinecke, A. Richieri-Costa, E.H. Zackai, J. Massague, M. Muenke, S.J. Elledge Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination Nat Genet 25 2000 205 208
23. L. Bartholin, T.A. Melhuish, S.E. Powers, S. Goddard-Leon, I. Treilleux, A.E. Sutherland, D. Wotton Maternal Tgif is required for vascularization of the embryonic placenta Dev Biol 319 2008 285 297
24. T. Horie, K. Ono, M. Kinoshita, H. Nishi, K. Nagao, T. Kawamura, Y. Abe, H. Wada, A. Shimatsu, T. Kita, K. Hasegawa TG-interacting factor is required for the differentiation of preadipocytes J Lipid Res 49 2008 1224 1234
25. R. Hamid, S.J. Brandt Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells Mol Oncol 3 2009 451 463
26. R. Hamid, J. Patterson, S.J. Brandt Genomic structure, alternative splicing and expression of TG-interacting factor, in human myeloid leukemia blasts and cell lines Biochim Biophys Acta 1779 2008 347 355
27. I. Imoto, A. Pimkhaokham, T. Watanabe, F. Saito-Ohara, E. Soeda, J. Inazawa Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE superclass, in ovarian cancer cell lines Biochem Biophys Res Commun 276 2000 264 270
28. C. Voorter, S. Joos, P.P. Bringuier, M. Vallinga, P. Poddighe, J. Schalken, S. du Manoir, F. Ramaekers, P. Lichter, A. Hopman Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization Am J Pathol 146 1995 1341 1354
29. J. Yen-Ping Ho, W.C. Man, Y. Wen, M.L. Polan, E. Shih-Chu Ho, B. Chen Transforming growth interacting factor expression in leiomyoma compared with myometrium Fertil Steril 94 2010 1078 1083
30. R.S. Lo, D. Wotton, J. Massague Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF EMBO J 20 2001 128 136
31. Z.L. Hu, J.F. Wen, D.S. Xiao, H. Zhen, C.Y. Fu Effects of transforming growth interacting factor on biological behaviors of gastric carcinoma cells World J Gastroenterol 11 2005 84 88
32. J. Borlak, T. Meier, R. Halter, R. Spanel, K. Spanel-Borowski Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours Oncogene 24 2005 1809 1819
33. J. Richter, L. Beffa, U. Wagner, P. Schraml, T.C. Gasser, H. Moch, M.J. Mihatsch, G. Sauter Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization Am J Pathol 153 1998 1615 1621
34. L. Dyrskjot, M. Kruhoffer, T. Thykjaer, N. Marcussen, J.L. Jensen, K. Moller, T.F. Orntoft Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification Cancer Res 64 2004 4040 4048
35. M. Sanchez-Carbayo, N.D. Socci, J. Lozano, F. Saint, C. Cordon-Cardo Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays J Clin Oncol 24 2006 778 789
36. S.J. Chatterjee, R. Datar, D. Youssefzadeh, B. George, P.J. Goebell, J.P. Stein, L. Young, S.R. Shi, C. Gee, S. Groshen, D.G. Skinner, R.J. Cote Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma J Clin Oncol 22 2004 1007 1013
37. S.F. Shariat, R. Ashfaq, A.I. Sagalowsky, Y. Lotan Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma J Urol 177 2007 481 487
38. S.F. Shariat, H. Tokunaga, J. Zhou, J. Kim, G.E. Ayala, W.F. Benedict, S.P. Lerner p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer J Clin Oncol 22 2004 1014 1024
39. R. Buccione, J.D. Orth, M.A. McNiven Foot and mouth: podosomes, invadopodia and circular dorsal ruffles Nature Rev Mol Cell Biol 5 2004 647 657
40. A.M. Weaver Invadopodia: specialized cell structures for cancer invasion Clin Exp Metastasis 23 2006 97 105
41. A.J. Ridley Life at the leading edge Cell 145 2011 1012 1022
42. M.A. Knowles, F.M. Platt, R.L. Ross, C.D. Hurst Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer Cancer Metastasis Rev 28 2009 305 316
43. L.C. Kompier, I. Lurkin, M.N. van der Aa, B.W. van Rhijn, T.H. van der Kwast, E.C. Zwarthoff FGFR3. HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy PLoS One 5 2010 e13821
44. H. Wallerand, Y. Cai, Z.A. Wainberg, I. Garraway, I. Lascombe, G. Nicolle, J.P. Thiery, H. Bittard, F. Radvanyi, R.R. Reiter Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines Urol Oncol 28 2010 180 188
45. J.W. Harper, G.R. Adami, N. Wei, K. Keyomarsi, S.J. Elledge The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 1993 805 816
46. M. Malumbres, M. Barbacid Cell cycle CDKs and cancer: a changing paradigm Nat Rev Cancer 9 2009 153 166
47. D.S. Hoon, M. Kitago, J. Kim, T. Mori, A. Piris, K. Szyfelbein, M.C. Mihm Jr., S.D. Nathanson, T.P. Padera, A.F. Chambers, S.A. Vantyghem, I.C. MacDonald, S.C. Shivers, M. Alsarraj, D.S. Reintgen, B. Passlick, W. Sienel, K. Pantel Molecular mechanisms of metastasis Cancer Metastasis Rev 25 2006 203 220
48. S.F. Shariat, P.I. Karakiewicz, R. Ashfaq, S.P. Lerner, G.S. Palapattu, R.J. Cote, A.I. Sagalowsky, Y. Lotan Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy Cancer 112 2008 315 325
49. WAF1/CIP1 expression on tumor progression in bladder cancer J Natl Cancer Inst 90 1998 1072 1079
50. E.S. Clark, A.S. Whigham, W.G. Yarbrough, A.M. Weaver Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia Cancer Res 67 2007 4227 4235
51. T. Yoshio, T. Morita, Y. Kimura, M. Tsujii, N. Hayashi, K. Sobue Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation FEBS Lett 581 2007 3777 3782
52. B. Desai, T. MA, M.A. Chellaiah Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion J Biol Chem 283 2008 13856 13866
53. M. Sutoh, Y. Hashimoto, T. Yoneyama, H. Yamamoto, S. Hatakeyama, T. Koie, A. Okamoto, K. Yamaya, H. Saitoh, T. Funyu, T. Nakamura, T. Sato, C. Ohyama, S. Tsuboi Invadopodia formation by bladder tumor cells Oncol Res 19 2010 85 92
54. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
55. C. Denicourt, S.F. Dowdy Cip/Kip proteins: more than just CDKs inhibitors Genes Dev 18 2004 851 855
56. N.E. Hynes, G. MacDonald ErbB receptors and signaling pathways in cancer Curr Opin Cell Biol 21 2009 177 184
57. Cip/WAF1 and promotes cell survival J Biol Chem 277 2002 11352 11361
58. L. Mar, P.A. Hoodless Embryonic fibroblasts from mice lacking Tgif were defective in cell cycling Mol Cell Biol 26 2006 4302 4310